Clinical Trial Update: A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2b randomized, double-blind study of Redasemtide (S-005151) in adults with acute ischemic stroke is underway. The trial status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Redasemtide (S-005151)

Snippet

Sponsor: Shionogi | Conditions: Acute Ischemic Stroke | Phase 2 | Status: ACTIVE_NOT_RECRUITING